CANKADO at the 41st annual conference of the German Society of Senology

Munich, Germany, 04.07.22 – After two years of the pandemic, CANKADO was delighted to attend the f2f conference again. It was clearly noticeable that digitization in cancer therapy is increasingly gaining momentum. Even though different approaches are being taken, we are united by the idea of supporting patients and healthcare providers alike. 

Besides groundbreaking discussions on the progress of digitization in cancer therapy, we presented OMCAT (“One Million Cancer Treatment Months”), the world’s largest artificial intelligence-based clinical trial in oncology, on site. This was initiated by CANKADO. The interest in OMCAT was very encouraging, and we were able to recruit additional centers for the project. OMCAT uses innovative methods and artificial intelligence to develop a predictive algorithm to optimize the care of cancer patients. In the future, this algorithm will identify patients at risk and predict adverse events, thereby making a lasting contribution to patient safety. 

Furthermore, the digital health application (DiGA), PRO-React Onco and the Companion Apps from CANKADO were subject of the discussion, as innovative solutions to digitally accompany patients and doctors during treatment.